Barclays Maintains Equal-Weight on Alcon, Raises Price Target to $80
Barclays analyst Christopher Pasquale maintains Alcon (NYSE:ALC) with a Equal-Weight and raises the price target from $70 to $80.
Last updated: 2026-11-19 02:28:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Alcon Inc. (ALC) operates in the -- sector and is listed on NYSE. The stock is currently priced at $75.23, with a market capitalization of $35.38B and a P/E ratio of 80.91. Over the past 52 weeks, its price has ranged from $61.84 to $87.64. This page covers its latest market performance, valuation, price trends and company information.
$35.38B | |
$73.41 | |
$75.50 | |
$71.68 | |
$74.11 | |
3.95M | |
1.89M | |
80.91 | |
$87.64 | |
$61.84 | |
-- | |
2026-09-30 |
Alcon Inc. (ALC) last closed at $75.23 as of 2026-11-19 00:31:00, up 1.55% ($1.15) from the previous close of $74.11.
During the latest regular trading session, ALC traded between $71.68 and $75.50, with a volume of 3.95M shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, Alcon Inc. (ALC) moved from $75.14 to $75.23, representing a gain of 0.12% ($0.09).
The stock traded between $70.34 and $75.71 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 3.52 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 51.9%
ALC is currently trading at $75.23, placing it 51.9% of the way from its 52-week low of $61.84 to its 52-week high of $87.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
| Employees | 25,942 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Alcon Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | May 6, 2026 |
| Payment Date | May 7, 2026 |
| Dividend Per Share | $0.28 |
Latest news related to Alcon Inc. and ALC stock.
Barclays analyst Christopher Pasquale maintains Alcon (NYSE:ALC) with a Equal-Weight and raises the price target from $70 to $80.
Baird analyst Jeff Johnson maintains Alcon (NYSE:ALC) with a Outperform and lowers the price target from $90 to $87.
Analysts cut targets and ratings for General Mills, Redwood Trust and Evgo, while raising targets for Radcom, Royal Caribbean and others.
Stifel analyst Thomas Stephan maintains Alcon (NYSE:ALC) with a Hold and lowers the price target from $70 to $65.
Alcon reported Q3 2026 earnings with ~6% full-year net sales growth guidance and double-digit core EPS growth. The company is defending its premium intraocular lens market share against competitors through new products (Vivity Pro, TruPlus), expanding UNITY surgical equipment placements to 40% of U.S. teaching hospitals, and acquiring Neurotech Pharmaceuticals for retinal disease treatment with peak sales potential of $250-400 million. Management emphasized outpacing the 3% baseline eye care market growth through operational efficiency and margin expansion.
Eligible investors can buy real shares of Alcon Inc. (ALC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ALC, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ALC shares and USD.
ALC Shares to USD
1.00 ALC shares = 75.231 USD
Calculations are estimates based on the latest available price and are for reference only.